SEKISUI KYDEX is an independent American company owned by the Japanese company SEKISUI Chemical Group. SEKISUI KYDEX is also a member of the SEKISUI America Corporation (SAC), which provides shared corporate resources to all US-based SEKISUI companies.
The core values that connect SEKISUI KYDEX with SEKISUI Chemical and SEKISUI America Corporation are Speed, Service, and Superiority.
Service We serve our stakeholders by creating social, environmental, and economic value through responsible business practices.
Speed We accelerate innovation by eagerly taking on new challenges, adapting to change, and staying ahead of the times.
Superiority We contribute to society by helping to solve social issues with our superior technologies and quality.
Learn more about WHY SEKISUI?
SEKISUI Chemical Group
SEKISUI Chemical Group is a global company that delivers a wide range of products and services that enrich people’s lives by providing housing, urban infrastructure, and chemical solutions.
Globally Expanding Group Businesses
The company is comprised of core businesses and technologies in the automotive material, medical, molding and processing, electronics, pipeline rehabilitations, and housing fields. Encouraging these core businesses to work together deepens their bonds and allows us to create a wide variety of technologies and products, as well as expand business globally in a broad range of areas.
SAC is the North America group of SEKISUI Chemical companies.
Comprised of ten companies, SAC is focused on providing solutions that help people overcome today’s challenges while fueling the world for a better tomorrow. The organization promotes professional and personal development that is reinforced by a commitment to inclusion, diversity, and equality. Because of these values, it brings carefully considered benefits to the market, such as:
Manufacturing solutions that reduce weight, fuel consumption, and wear and tear, all to help conserve resources.
Our healthcare companies are involved in early-phase clinical evaluations and trials as well as early-stage diagnostic testing. These efforts help manufacturing companies refine drug compounds faster, reducing the chances of toxic effects on the body. Faster diagnosis leads to quicker treatment and accelerated recovery time.
Environment-focused practices help protect our natural resources, significantly reduce the environmental impact of maintenance, and lower rehabilitation costs.